DK2921171T3 - Oftalmiske, intraartikulære eller intravesikale præparater indeholdende n-acyl-ethanolaminer - Google Patents

Oftalmiske, intraartikulære eller intravesikale præparater indeholdende n-acyl-ethanolaminer Download PDF

Info

Publication number
DK2921171T3
DK2921171T3 DK15156130.5T DK15156130T DK2921171T3 DK 2921171 T3 DK2921171 T3 DK 2921171T3 DK 15156130 T DK15156130 T DK 15156130T DK 2921171 T3 DK2921171 T3 DK 2921171T3
Authority
DK
Denmark
Prior art keywords
intra
ethanolamines
articular
ophthalmic
acyl
Prior art date
Application number
DK15156130.5T
Other languages
English (en)
Inventor
Valle Francesco Della
Sebastiano Mangiafico
Valle Maria Federica Della
Original Assignee
Epitech Group S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epitech Group S P A filed Critical Epitech Group S P A
Application granted granted Critical
Publication of DK2921171T3 publication Critical patent/DK2921171T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/133Amines having hydroxy groups, e.g. sphingosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/007Polyrotaxanes; Polycatenanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK15156130.5T 2014-03-21 2015-02-23 Oftalmiske, intraartikulære eller intravesikale præparater indeholdende n-acyl-ethanolaminer DK2921171T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI20140477 2014-03-21
ITMI20141491 2014-08-12

Publications (1)

Publication Number Publication Date
DK2921171T3 true DK2921171T3 (da) 2020-01-27

Family

ID=52484404

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15156130.5T DK2921171T3 (da) 2014-03-21 2015-02-23 Oftalmiske, intraartikulære eller intravesikale præparater indeholdende n-acyl-ethanolaminer

Country Status (8)

Country Link
US (1) US9668986B2 (da)
EP (1) EP2921171B1 (da)
CA (1) CA2885443C (da)
CY (1) CY1122484T1 (da)
DK (1) DK2921171T3 (da)
ES (1) ES2772252T3 (da)
HU (1) HUE047471T2 (da)
PT (1) PT2921171T (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700120375A1 (it) * 2017-10-24 2019-04-24 For Health Pharma S R L Soluzioni acquose stabili che comprendono PUFAs
IT201900000561A1 (it) * 2019-01-14 2020-07-14 Medivis S R L Formulazioni topiche oftalmiche chimicamente e fisicamente stabili a base di Nepafenac

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58126810A (ja) * 1981-12-24 1983-07-28 Kaken Pharmaceut Co Ltd 抗炎症眼科用液剤およびその製法
US5631297A (en) * 1994-07-11 1997-05-20 Pate; David W. Anandamides useful for the treatment of intraocular hypertension, ophthalmic compositions containing the same and methods of use of the same
TWI250023B (en) * 2001-10-22 2006-03-01 Santen Pharmaceutical Co Ltd Pharmaceutical composition for itch treating agent
JP5746178B2 (ja) * 2009-09-07 2015-07-08 エピテック・グループ・エス.アール.エル. 超微粉化パルミトイル−エタノールアミドを含む組成物
ES2648051T3 (es) * 2010-10-04 2017-12-28 Epitech Group S.P.A. Uso de amidas de ácidos mono y dicarboxílicos en el tratamiento de enfermedades renales
PT2814489T (pt) * 2012-02-17 2017-10-23 Epitech Group S P A Composições e métodos para a modulação de amidases específicas para n-aceiletanolaminas para utilização na terapia de doenças inflamatórias
ITMI20122127A1 (it) * 2012-12-13 2014-06-14 Epitech Group Srl Derivati polietilenglicolici di palmitoiletanolammide e aciletanolammidi analoghe

Also Published As

Publication number Publication date
EP2921171A1 (en) 2015-09-23
HUE047471T2 (hu) 2020-04-28
CA2885443A1 (en) 2015-09-21
EP2921171B1 (en) 2019-10-16
ES2772252T3 (es) 2020-07-07
CA2885443C (en) 2022-11-29
CY1122484T1 (el) 2021-01-27
PT2921171T (pt) 2020-01-21
US9668986B2 (en) 2017-06-06
US20150265551A1 (en) 2015-09-24

Similar Documents

Publication Publication Date Title
IL264454A (en) Novel compositions, uses and methods for making them
DK3778903T3 (da) Trisegmenterede arenavira som vaccinevektorer
SI3536380T1 (sl) Hitro delujoči pripravki inzulina
HUE053101T2 (hu) Javított T-sejt-készítmények
DK3229810T3 (da) Phospholipid-ether-analoger som kræftrammende lægemiddelvehikler
IL247262B (en) Cannabinoid compositions and uses
LT3230281T (lt) 1,3-tiazol-2-ilu pakeisti benzamidai
DK3108000T3 (da) Adeno-associeret virusvektor
HUE054344T2 (hu) Gyógyászati készítmények AZD9291 tartalommal
DK3207053T3 (da) Hidtil ukendte immunogene peptider
IL256939B (en) Rapid-acting insulin compositions
PL3368014T3 (pl) Nowe preparaty kannabinoidów
DK3308688T3 (da) Opvaskemaskine i form af en kommerciel bestikopvaskemaskine eller opvaskemaskine, designet som en batch-opvaskemaskine
DK3130392T3 (da) Virusfjernelsesmembran
DK3171701T3 (da) Infusionsanlæg
EP3130393A4 (en) Virus removal membrane
FR3023171B1 (fr) Autoinjecteur.
HUE053624T2 (hu) Ciklosporint tartalmazó készítmények
DK3164410T3 (da) Protein-indvinding
SMT202200179T1 (it) Composizione acquosa oftalmica.
IL249254A0 (en) Gene expression system
DK3337353T3 (da) Stol
FR3023170B1 (fr) Autoinjecteur.
HUE045746T2 (hu) Eljárás fûszerkészítmények elõállítására
EP3216868A4 (en) Virus vector, cell, and construct